|Positive ELISA detected in||Recombinant protein|
|Enzyme-linked Immunosorbent Assay (ELISA)||ELISA : |
|Sample-dependent, check data in validation data gallery|
28904-1-AP targets SARS-CoV-2 Envelope Protein in IF, ELISA applications and shows reactivity with virus samples.
|Host / Isotype||Rabbit / IgG|
|Immunogen||SARS-CoV-2 Envelope Protein fusion protein Ag30690|
|Full Name||COVID-19 E Protein|
|GenBank accession number||NC_045512|
|Gene symbol||COVID-19 E Protein|
|Gene ID (NCBI)||43740570|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).